当前位置:首页 > 报告详情

重组胶原蛋白在化妆品中的应用.pdf

上传人: 探** 编号:711756 2025-06-04 51页 5.07MB

1、Application of Recombinant Collagen in CosmeticsShengwei Fu,Ph.D.Jiangsu Trautec Medical Technology Co.,Ltd.1Established in 20152015Operate a 300,000-square-foot production facility in Jiangsu,China300,000Recombinant collagen core sequence patents7Company OverviewOn August 10,2022,Trauteccompleted i

2、ts first round of200 million RMB financing,ledby ShiseidoOn November 15,2022,TrautecandShiseidoChinabegancooperation in medical beautyIn 2023,Trautec completed200 million RMB series Bfundraise led by L CattertonPartnershipRecombinant collagen:rhCol IIIrhCol IAnti-ageing in dermisAnti-ageing in dermi

3、srhCol XVIIAnti-ageing in basement membraneAnti-hair lossLow molecular weight rhColBetter penetrationcapacityProducts overview rhCol IVAnti-ageing in basement membranerhCol VIIAnti-ageing in basement membranerhCol VIAnti-ageing in dermis&basement membranerhCol IIUnique typeWith a view to a sustainab

4、le future,Trautec is further investing in biosynthesis research and innovation.Our green biomanufacturing approach through cell factories improves productivity and also reduces greenhouse gas emissions.Trautec strives to explore science and technology to promote low carbon emission reduction and gre

5、en production.We are moving forward together towards a better future and ultimately achieving a sustainable social ecology.Trautec has successfully applied ISO14064 for enterprise,ISO14067 for product carbon footprint.Green,Sustainable,Environmental friendly Constructing a restructured futureNo Anim

6、al TestsMild and harmlessLow carbon emission reductionSustainble developmentAs a leading company in the synthetic biology,Trautec has successfully gained Bronze Medal byEcovadis certificate.We are dedicated to practising ESG principles,and moving toward a green,sustainable,and regenerative world.Sus

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了江苏泰奥特医科技有限公司在重组胶原蛋白领域的研发和应用。以下是关键点: 1. 泰奥特医成立于2015年,拥有300,000平方英尺的生产设施,专注于重组胶原蛋白的研发,拥有7项核心序列专利。 2. 2022年,公司完成B轮融资,市场对重组胶原蛋白产品的需求持续增长,预计2027年市场规模将达到108.3亿人民币。 3. 重组胶原蛋白在化妆品、医疗美容等领域具有广泛的应用,可抗衰老、修复皮肤、调节细胞行为等。 4. 泰奥特医的MiniReCol®系列产品具有高纯度、生物活性强、渗透性好等特点,可促进胶原蛋白生成,抵抗炎症和氧化应激。 5. 实验结果显示,MiniReCol®系列产品能显著提升皮肤屏障功能,增加皮肤弹性和厚度,减少细纹和红肿。 参考文献中的核心数据:市场规模预测从2017年的1.5亿增长至2027年的108.3亿人民币,重组胶原蛋白在功能性护肤品市场占比逐年上升。
"重组胶原蛋白,美肤新趋势?" "小分子胶原蛋白,效果神奇吗?" "绿色护肤,你了解多少?"
客服
商务合作
小程序
服务号
折叠